Effect of a New Beta-Blocker, Nipradilol, on Cardiac Function and Neurohumoral Factors in Idiopathic Dilated Cardiomyopathy

This study investigated the therapeutic efficacy of a new beta-blocker, nipradilol, a non-selective agent with vasodilating activity, for the treatment of idiopathic dilated cardiomyopathy (DCM). The New York Heart Association functional class improved in the nipradilol group (n=9, p

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAPANESE CIRCULATION JOURNAL 1996, Vol.60(5), pp.285-292
Hauptverfasser:	Yoshikawa, Tsutomu, Handa, Shunnosuke, Akaishi, Makoto, Mitamura, Hideo, Ogawa, Satoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Adult Aged Atrial Natriuretic Factor - blood Atrial natriuretic peptide Beta-blocker Biological and medical sciences Cardiomyopathy, Dilated - blood Cardiomyopathy, Dilated - drug therapy Cardiomyopathy, Dilated - physiopathology Cardiovascular system Dilated cardiomyopathy Female Heart failure Heart Rate - drug effects Humans Male Medical sciences Middle Aged Norepinephrine Norepinephrine - blood Pharmacology. Drug treatments Propanolamines - therapeutic use Vasodilator agents. Cerebral vasodilators Ventricular Function, Left - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!